LoginRegister
    Unichem Labs net loss narrows to Rs 22 crore in September quarterUnichem Labs net loss narrows to Rs 22 crore in September quarter
    DoP invites nominations for 5th India Pharma and Medical Device AwardsDoP invites nominations for 5th India Pharma and Medical Device Awards
    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDAStrides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA
    Transasia-Erba group unveils TB testing device MX 16Transasia-Erba group unveils TB testing device MX 16
    Medtronic launches Valiant Navion Thoracic Stent Graft System in JapanMedtronic launches Valiant Navion Thoracic Stent Graft System in Japan
    GSK Benlysta gets European nod for treatment of children with lupusGSK Benlysta gets European nod for treatment of children with lupus
    AbbVie says multiple parties vying for assets related to Allergan deal approvalAbbVie says multiple parties vying for assets related to Allergan deal approval
    CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulationsCDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations
    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate InjectionIndoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection
    Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks OfficeStempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office
    Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistakeAnother delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake
    Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 croreDr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X